Amniotic MSCs reduce pulmonary fibrosis by hampering lung B‐cell recruitment, retention, and maturation

Growing evidence suggests a mechanistic link between inflammation and the development and progression of fibrotic processes. Mesenchymal stromal cells derived from the human amniotic membrane (hAMSCs), which display marked immunomodulatory properties, have been shown to reduce bleomycin‐induced lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Cargnoni, Anna, Romele, Pietro, Bonassi Signoroni, Patrizia, Farigu, Serafina, Magatti, Marta, Vertua, Elsa, Toschi, Ivan, Cesari, Valentina, Silini, Antonietta R., Stefani, Francesca R., Parolini, Ornella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Fetal and Neonatal Stem Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445028/
https://www.ncbi.nlm.nih.gov/pubmed/32452646
http://dx.doi.org/10.1002/sctm.20-0068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445028/
https://www.ncbi.nlm.nih.gov/pubmed/32452646
http://dx.doi.org/10.1002/sctm.20-0068

Ejemplares similares